glp 1 drugs for parkinson's disease The Emerging Role of GLP-1 RAs in Ozempic and other GLP-1 drugs

10.1097/01.aud.0000191942.36672.f3 28 HightN

Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease

The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)

Lifestyle and unhealthy diet is the leading cause of liver diseases in almost all western countries

doi: 10.1523/JNEUROSCI.23-28-09418.2003 48 FilbinM

2011;41(5):346-DOI: 10.2519/jospt.2011.322553